secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001104659-25-085658
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics gets Nasdaq extension to Feb 2026 for bid price compliance; transfers to Capital Market
--------------------------------------------------------------------------------

- Received 180-day extension until Feb 23, 2026 to meet $1.00 minimum bid price rule after Aug 26 initial deadline.
- Nasdaq approved transfer from Global Select to Capital Market effective Aug 27, 2025; stock continues under IPSC.
- Company will consider a reverse stock split to cure the bid price deficiency.
- No assurance of regaining compliance; delisting remains possible if price fails to close at $1.00 for 10 consecutive days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925085658/0001104659-25-085658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925085658/tm2524509d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-085658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer